Checked.be
Active
BE 0800.381.939Private limited company
HUMAN PHARMA
Rue du Sanatorium 36 ·6001 Charleroi, Belgium· 3 yrs active
Sector: Retail trade
(47730)
Conclusion
The computed 12-month bankruptcy probability of HUMAN PHARMA is 2.3% (moderate). The 2024 annual accounts show equity of €178k and a net result of €85k. Its solvency ranks better than 69% of 864 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Key figures
| Equity | €178k |
| Net result | €85k |
| Staff (FTE) | 0.7 |
| Better than sector | 69% |
Snowflake analysis
78
/ 100
Exceptional profile, strong across almost every axis.
Health
81
Profitability
100
Solvency
61
Growth
52
Stability
94
Bankruptcy probability (12 mo)
2.3%
Moderate
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate sector
+Higher-failure-rate region
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
No administrative flags
Health barometer
81
/ 100
Excellent
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Financial overview
Annual accounts filed on 08-11-2025 with the NBB · fiscal year 2024 · volledig
Sector comparison
Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 33.1% | 17.5% | |
| Net result | €85k | €14k | |
| Equity | €178k | €101k | |
| Gross operating margin | €162k | €213k | |
| Staff costs | €30k | €219k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€125k
-50.9%
-8% vs sector
€85k
-50.6%
+80% vs sector
€97k
-50.6%
-12% vs sector
€538k
-12.8%
-23% vs sector
€178k
+1.9%
-47% vs sector
€135k
-
-53% vs sector
1
-
-73% vs sector
€30k
-14.2%
-79% vs sector
€23k
-61.9%
+53% vs sector
€351k
-20.7%
-4% vs sector
€338k
-23.6%
+18% vs sector
€13k
-
-93% vs sector
1.40
+222.5%
-30% vs sector
1.21
+179.0%
-10% vs sector
33.1%
+16.9%
-31% vs sector
1.97
-22.2%
+80% vs sector
47.6%
-51.6%
+238% vs sector
15.7%
-43.4%
+134% vs sector
22.80
-73.2%
+92% vs sector
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €125k |
| Net profit | €85k |
| Cash flow | €97k |
| Staff costs | €30k |
| Income taxes | €23k |
| Dividends | - |
| Total assets | €538k |
| Equity | €178k |
| Debt | €351k |
| of which ≤ 1y | €338k |
| of which > 1y | €13k |
| Working capital | €135k |
| Employees (FTE) | 0.7 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 1.40 |
| Quick ratio | 1.21 |
| Working capital ratio | 25.0% |
| Solvency | 33.1% |
| Debt / equity | 1.97 |
| Long-term debt ratio | 0.07 |
| Interest coverage | 22.80 |
| Gross margin | - |
| Net margin | - |
| ROA | 15.7% |
| ROE | 47.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | 73d |
| Inventory turnover | 14.08 |
| Days inventory (DSI) | 26d |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €538k |
| Fixed assets | 21/28 | €65k |
| Intangible fixed assets | 21 | €22k |
| Tangible fixed assets | 22/27 | €43k |
| Current assets | 29/58 | €473k |
| Stocks & contracts in progress | 3 | €64k |
| Amounts receivable within one year | 40/41 | €394k |
| Cash & bank | 54/58 | €15k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €538k |
| Equity | 10/15 | €178k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €175k |
| Provisions & deferred taxes | 16 | €9k |
| Amounts payable | 17/49 | €351k |
| Amounts payable after one year | 17 | €13k |
| Amounts payable within one year | 42/48 | €338k |
| Trade debts payable within one year | 44 | €179k |
| Income statement | ||
| Gross operating margin | 9900 | €162k |
| Operating result | 9901 | €113k |
| Financial income | 75 | €238 |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €107k |
| Income taxes | 67/77 | €23k |
| Net result for the period | 9904 | €85k |
| Result to be appropriated | 9905 | €85k |
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Legal Structure
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 04-04-2023 |
| Status | Active |
| Postal code | 6001 |
Establishment units
HUMAN PHARMA
since 20232.344.514.744
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52392D0104/00T014 | Wallonia | 835 m² | 1 · 180 m² | 7.5 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
08-11-2025
NBB filing
Annual accounts filed
2024
04-11-2024
NBB filing
Annual accounts filed
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE)
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels47740Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen47741Detailhandel in cosmetica en toiletartikelen in gespecialiseerde winkels47750Detailhandel in cosmetica en toiletartikelen47750
Primary activity highlighted.
Names & trade names
| Legal nameFR | HUMAN PHARMA |
Registered office
Rue du Sanatorium 36
6001 Charleroi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
APOTHEEK D. JANS
BE 0429.073.659 · Antwerpen
APOTHEEK STAEREN-CORION
BE 0420.528.256 · Sint-Laureins
Apotheek De Gendt
BE 0422.288.609 · Antwerpen
Apham
BE 0414.244.042 · Antwerpen
APOTHEEK FRANSEN
BE 0428.233.422 · Zoersel